Zenobia D’Costa

885 total citations
14 papers, 655 citations indexed

About

Zenobia D’Costa is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Zenobia D’Costa has authored 14 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Zenobia D’Costa's work include Pancreatic and Hepatic Oncology Research (6 papers), Neuroendocrine Tumor Research Advances (3 papers) and Biochemical and Structural Characterization (2 papers). Zenobia D’Costa is often cited by papers focused on Pancreatic and Hepatic Oncology Research (6 papers), Neuroendocrine Tumor Research Advances (3 papers) and Biochemical and Structural Characterization (2 papers). Zenobia D’Costa collaborates with scholars based in United Kingdom, Canada and Germany. Zenobia D’Costa's co-authors include Ruth J. Muschel, W. Gillies McKenna, Emmanouil Fokas, Stanley K. Liu, Paul B. Mullan, Niamh E. Buckley, Nyree Crawford, Owen J. Sansom, Abul Kalam Azad and Su Yin Lim and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Zenobia D’Costa

14 papers receiving 652 citations

Peers

Zenobia D’Costa

ONCOL

IMMUN

PRM

Natascha Cremers Germany

Ryotaro Ogawa Japan

Emily Capone Italy

Yasemin Kaygusuz United States

Almudena Santos United Kingdom

Serena Lunardi United Kingdom

Qitai Zhao China

Vivien Koh Singapore

Magali Castells France

Sophia Bornstein United States

Natascha Cremers Germany

Zenobia D’Costa

290 ×0.7

ONCOL

239 ×0.9

92 ×0.5

IMMUN

137 ×1.2

63 ×0.8

PRM

Citations per year, relative to Zenobia D’Costa Zenobia D’Costa (= 1×) peers Natascha Cremers

Countries citing papers authored by Zenobia D’Costa

Since Specialization

Citations

This map shows the geographic impact of Zenobia D’Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zenobia D’Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zenobia D’Costa more than expected).

Fields of papers citing papers by Zenobia D’Costa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zenobia D’Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zenobia D’Costa. The network helps show where Zenobia D’Costa may publish in the future.

Co-authorship network of co-authors of Zenobia D’Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Zenobia D’Costa. A scholar is included among the top collaborators of Zenobia D’Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zenobia D’Costa. Zenobia D’Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Bhalla, Sheena, Farjana Fattah, Jessica N. Williams, et al.. (2022). Phase 1 dose escalation and expansion study of bemcentinib (BGB324), a first-in-class, selective AXL inhibitor, with docetaxel in patients with previously treated advanced NSCLC.. Journal of Clinical Oncology. 40(16_suppl). 9081–9081. 5 indexed citations

Crawford, Nyree, et al.. (2019). TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells. Oncogene. 38(31). 5971–5986. 38 indexed citations

D’Costa, Zenobia, Keaton Jones, Abul Kalam Azad, et al.. (2017). Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer. Cancer Research. 77(21). 5952–5962. 51 indexed citations

Azad, Abul Kalam, Su Yin Lim, Zenobia D’Costa, et al.. (2016). PD ‐L1 blockade enhances response of pancreatic ductal adenocarcinoma to radiotherapy. EMBO Molecular Medicine. 9(2). 167–180. 175 indexed citations

Wang, Lai Mun, Zenobia D’Costa, Paul Allen, et al.. (2016). Prognostic value, localization and correlation of PD-1/PD-L1, CD8 and FOXP3 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Oncotarget. 7(27). 40992–41004. 67 indexed citations

Wang, Lai Mun, Zenobia D’Costa, Abul Kalam Azad, et al.. (2016). Prognostic role and correlation of CA9, CD31, CD68 and CD20 with the desmoplastic stroma in pancreatic ductal adenocarcinoma. Oncotarget. 7(45). 72819–72832. 16 indexed citations

Johnston, Rebecca L., Zenobia D’Costa, Swagat Ray, et al.. (2016). The identification of a novel role for BRCA1 in regulating RNA polymerase I transcription. Oncotarget. 7(42). 68097–68110. 19 indexed citations

Eddie, Sharon L., Catherine Higgins, Zenobia D’Costa, et al.. (2015). Development of a potent and selective cell penetrant Legumain inhibitor. Bioorganic & Medicinal Chemistry Letters. 25(23). 5642–5645. 15 indexed citations

Wang, Lai Mun, Michael A. Silva, Zenobia D’Costa, et al.. (2015). The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma. Oncotarget. 7(4). 4183–4194. 93 indexed citations

10.

Buckley, Niamh E., Zenobia D’Costa, Marzena Kamińska, & Paul B. Mullan. (2014). S100A2 is a BRCA1/p63 coregulated tumour suppressor gene with roles in the regulation of mutant p53 stability. Cell Death and Disease. 5(2). e1070–e1070. 27 indexed citations

11.

Higgins, Catherine, Zenobia D’Costa, Martin O’Rourke, et al.. (2014). P3 SAR exploration of biphenyl carbamate based Legumain inhibitors. Bioorganic & Medicinal Chemistry Letters. 24(11). 2521–2524. 9 indexed citations

12.

D’Costa, Zenobia, Catherine Higgins, Chee Wee Ong, et al.. (2014). TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities.. Oncotarget. 5(6). 1609–1620. 36 indexed citations

13.

Buckley, Niamh E., Jaine K. Blayney, Nyree Crawford, et al.. (2013). BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers. Nucleic Acids Research. 41(18). 8601–8614. 44 indexed citations

14.

Redmond, Keara L., Nyree Crawford, Hannah Farmer, et al.. (2010). T-box 2 represses NDRG1 through an EGR1-dependent mechanism to drive the proliferation of breast cancer cells. Oncogene. 29(22). 3252–3262. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact